# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 511-520 of 562 results.
Recommendations for the Treatment of Children With Burkitt's Lymphoma
Status: Not yet recruiting
Last Changed: Jun 18, 2020
First Received: Jun 11, 2020
Disease(s): Burkitt Lymphoma
Intervention(s): OBSERVATIONAL
Locations: CHU de Treichville à ABIDJAN, Abidjan, Côte D'Ivoire
Clinical Factors and Gene Expression Analysis for Prognosis in Tissue Samples From Patients With AIDS-Related Primary Effusion Lymphoma
Status: Recruiting
Last Changed: Oct 24, 2019
First Received: Jul 06, 2016
Disease(s): AIDS-Related Primary Effusion Lymphoma
Intervention(s): Laboratory Biomarker Analysis, Medical Chart Review
Locations: UC San Diego Moores Cancer Center, La Jolla, California, United States
UCLA CARE Center, Los Angeles, California, United States
University of Miami, Miami, Florida, United States
Stroger Hospital of Cook County, Chicago, Illinois, United States
Virginia Mason Medical Center, Seattle, Washington, United States
... and 1 other locations.
REal World Data in LYmphoma and Survival in Adults
Status: Recruiting
Last Changed: Mar 11, 2019
First Received: Mar 11, 2019
Disease(s): Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), T-cell Lymphoma (T-NHL), Hodgkin's Lymphoma (HL), Burkitt Lymphoma (BL))
Intervention(s): Real-life epidemiological platform of lymphoma in France
Locations: Institut Bergonié, Bordeaux, France
CHU Francois MITTERRAND, Dijon, France
CHD Vendée, La Roche-sur-Yon, France
CHU Haut-Lévêque, Pessac, France
Centre Hospitalier Lyon Sud, Pierre-Bénite, France
... and 3 other locations.
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
Status: Recruiting
Last Changed: Jun 11, 2020
First Received: Jun 13, 2016
Disease(s): HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma, Recurrent Follicular Lymphoma, Stage III Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage IV Follicular Lymphoma, Stage IV Mantle Cell Lymphoma
Intervention(s): Autologous Hematopoietic Stem Cell Transplantation, Carmustine, Cytarabine, Etoposide, Laboratory Biomarker Analysis, Lentivirus Vector CCR5 shRNA/TRIM5alpha/TAR Decoy-transduced Autologous CD34-positive Hematopoietic Progenitor Cells, Melphalan, Peripheral Blood Stem Cell Transplantation
Locations: UC San Diego Moores Cancer Center, La Jolla, California, United States
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
UCSF Medical Center-Parnassus, San Francisco, California, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Status: Not yet recruiting
Last Changed: Aug 04, 2020
First Received: Dec 12, 2019
Disease(s): Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult Diffuse Large Cell Lymphoma, Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Hodgkin Lymphoma, Lymphoblastic Lymphoma, Lymphoplasmacytic Lymphoma, Mantle Cell Lymphoma, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory Follicular Lymphoma, Refractory Marginal Zone Lymphoma, Refractory Small Lymphocytic Lymphoma
Intervention(s): Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cyclosporine, Filgrastim, Fludarabine, Mycophenolate Mofetil, Mycophenolate Sodium, Total-Body Irradiation, Treosulfan
Locations: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Mobile Health Case Management System for Reducing Pediatric Treatment Abandonment
Status: Recruiting
Last Changed: Jun 17, 2020
First Received: Sep 19, 2018
Disease(s): Burkitt Lymphoma, Retinoblastoma
Intervention(s): mNavigator
Locations: Bugando Medical Centre, Mwanza, Lake Zone, Tanzania
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Status: Recruiting
Last Changed: May 18, 2020
First Received: Sep 17, 2018
Disease(s): Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Biphenotypic/Undifferentiated Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia, Relapsed Large Cell Lymphoma, Mantle Cell Lymphoma, Hodgkin Lymphoma, Burkitt Lymphoma, Relapsed T-Cell Lymphoma, Lymphoplasmacytic Lymphoma
Intervention(s): Fludarabine (FLU), Cyclophosphamide (CY), Total Body Irradiation (TBI), Tacrolimus (Tac), Mycophenolate Mofetil (MMF), Granulocyte Colony-Stimulating Factor (G-CSF), Busulfan (BU), Melphalan, MGTA 456 Infusion
Locations: Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Status: Recruiting
Last Changed: Apr 24, 2020
First Received: Jan 18, 2019
Disease(s): Acute Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia, Mixed Lineage Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma, Juvenile Myelomonocytic Leukemia
Intervention(s): CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
Locations: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Status: Recruiting
Last Changed: Feb 25, 2020
First Received: Jul 22, 2008
Disease(s): Acute Biphenotypic Leukemia, Acute Myeloid Leukemia in Remission, Ann Arbor Stage I Burkitt Lymphoma, Ann Arbor Stage I Non-Hodgkin Lymphoma, Ann Arbor Stage II Burkitt Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Lymphoblastic Lymphoma, Mantle Cell Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Plasma Cell Myeloma, Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Follicular Lymphoma, Recurrent Lymphoplasmacytic Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Ann Arbor Stage II Non-Hodgkin Lymphoma, Ann Arbor Stage III Burkitt Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Burkitt Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, High Risk Acute Myeloid Leukemia, Refractory Anemia
Intervention(s): Cyclophosphamide, Cyclosporine, Double-Unit Umbilical Cord Blood Transplantation, Fludarabine, Laboratory Biomarker Analysis, Mycophenolate Mofetil, Total-Body Irradiation, Umbilical Cord Blood Transplantation, Thiotepa
Locations: University of Colorado Hospital, Aurora, Colorado, United States
VA Puget Sound Health Care System, Seattle, Washington, United States
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
Status: Recruiting
Last Changed: Apr 24, 2020
First Received: Dec 19, 2016
Disease(s): Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Lymphoma,Non-Hodgkin, Lymphoma, Hodgkin, Lymphoma, Follicular, Marginal Zone Lymphoma, Large Cell Lymphoma, Mantle-Cell Lymphoma, Gray Zone Lymphoma, Burkitt Lymphoma, High Risk Undifferentiated Acute Leukemia
Intervention(s): Bendamustine, Cyclophosphamide
Locations: The University of Arizona Cancer Center, Tucson, Arizona, United States